Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.73B | 12.75B | 13.07B | 12.56B | 11.57B | 9.95B |
Gross Profit | 7.30B | 7.35B | 7.36B | 6.84B | 6.45B | 5.62B |
EBITDA | 1.26B | 1.40B | 1.07B | 1.06B | 1.63B | 1.42B |
Net Income | 777.23M | 830.89M | 734.90M | 560.63M | 1.05B | 912.45M |
Balance Sheet | ||||||
Total Assets | 11.64B | 11.86B | 11.20B | 10.18B | 10.06B | 8.71B |
Cash, Cash Equivalents and Short-Term Investments | 3.78B | 4.23B | 3.13B | 2.62B | 2.82B | 1.42B |
Total Debt | 2.06B | 1.98B | 1.76B | 2.05B | 2.15B | 2.01B |
Total Liabilities | 3.95B | 3.92B | 3.96B | 3.51B | 3.91B | 3.60B |
Stockholders Equity | 7.70B | 7.94B | 7.25B | 6.67B | 6.16B | 5.11B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.18B | 907.84M | 33.62M | 1.33B | 488.57M |
Operating Cash Flow | 0.00 | 1.21B | 964.32M | 315.56M | 1.41B | 546.91M |
Investing Cash Flow | 0.00 | -102.41M | 10.99M | -361.40M | -94.15M | -88.92M |
Financing Cash Flow | 0.00 | -9.58M | -465.46M | -156.67M | 93.74M | -207.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.22B | 12.06 | 2.17% | -2.46% | 13.80% | ||
78 Outperform | ¥10.49B | 11.08 | 1.72% | 13.00% | -17.83% | ||
71 Outperform | ¥4.71B | 3.47 | 4.38% | 8.10% | 85.47% | ||
69 Neutral | ¥8.65B | 11.80 | 4.65% | 3.93% | 1.66% | ||
67 Neutral | ¥2.72B | 9.67 | ― | -1.07% | 6.60% | ||
61 Neutral | $41.24B | -0.79 | -14.21% | 3.80% | 2.39% | -73.52% | |
50 Neutral | ¥3.29B | 22.14 | ― | -13.42% | -195.53% |